Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023 20:49 ET
|
Neumora Therapeutics, Inc.
WATERTOWN, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (“Neumora”), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the...